BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15037019)

  • 1. Macrophage hypo-responsiveness to interferon-gamma in aged mice is associated with impaired signaling through Jak-STAT.
    Yoon P; Keylock KT; Hartman ME; Freund GG; Woods JA
    Mech Ageing Dev; 2004 Feb; 125(2):137-43. PubMed ID: 15037019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium avium infection of mouse macrophages inhibits IFN-gamma Janus kinase-STAT signaling and gene induction by down-regulation of the IFN-gamma receptor.
    Hussain S; Zwilling BS; Lafuse WP
    J Immunol; 1999 Aug; 163(4):2041-8. PubMed ID: 10438942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1.
    Bovolenta C; Lorini AL; Mantelli B; Camorali L; Novelli F; Biswas P; Poli G
    J Immunol; 1999 Jan; 162(1):323-30. PubMed ID: 9886402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-gamma stimuli.
    Hosui A; Ohkawa K; Ishida H; Sato A; Nakanishi F; Ueda K; Takehara T; Kasahara A; Sasaki Y; Hori M; Hayashi N
    J Biol Chem; 2003 Aug; 278(31):28562-71. PubMed ID: 12764155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania inhibits STAT1-mediated IFN-gamma signaling in macrophages: increased tyrosine phosphorylation of dominant negative STAT1beta by Leishmania mexicana.
    Bhardwaj N; Rosas LE; Lafuse WP; Satoskar AR
    Int J Parasitol; 2005 Jan; 35(1):75-82. PubMed ID: 15619518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.
    Takaoka A; Tanaka N; Mitani Y; Miyazaki T; Fujii H; Sato M; Kovarik P; Decker T; Schlessinger J; Taniguchi T
    EMBO J; 1999 May; 18(9):2480-8. PubMed ID: 10228162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase A-mediated inhibition of gamma interferon-induced tyrosine phosphorylation of Janus kinases and latent cytoplasmic transcription factors in human monocytes by Ehrlichia chaffeensis.
    Lee EH; Rikihisa Y
    Infect Immun; 1998 Jun; 66(6):2514-20. PubMed ID: 9596710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide.
    Morrison AC; Wilson CB; Ray M; Correll PH
    J Immunol; 2004 Feb; 172(3):1825-32. PubMed ID: 14734766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Jak-STAT pathway stimulated by interferon gamma.
    Horvath CM
    Sci STKE; 2004 Nov; 2004(260):tr8. PubMed ID: 15561980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2.
    Osaki M; Tan L; Choy BK; Yoshida Y; Cheah KS; Auron PE; Goldring MB
    Biochem J; 2003 Jan; 369(Pt 1):103-15. PubMed ID: 12223098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma-induced MHC class I expression and defects in Jak/Stat signalling in methylcholanthrene-induced sarcomas.
    Svane IM; Engel AM; Nielsen M; Werdelin O
    Scand J Immunol; 1997 Oct; 46(4):379-87. PubMed ID: 9350289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected transcriptional signals in normal and mitotically defective cells mediated through cytokine and growth factor receptors.
    Samanta A; Qian X; Greene MI
    DNA Cell Biol; 1995 Nov; 14(11):921-30. PubMed ID: 7576178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures.
    Dell'Albani P; Santangelo R; Torrisi L; Nicoletti VG; de Vellis J; Giuffrida Stella AM
    J Neurosci Res; 2001 Sep; 65(5):417-24. PubMed ID: 11536325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
    Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
    J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Jak-STAT pathway stimulated by interferon alpha or interferon beta.
    Horvath CM
    Sci STKE; 2004 Nov; 2004(260):tr10. PubMed ID: 15561979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.
    Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE
    Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired response to interferon-gamma in activated macrophages due to tyrosine nitration of STAT1 by endogenous nitric oxide.
    Llovera M; Pearson JD; Moreno C; Riveros-Moreno V
    Br J Pharmacol; 2001 Jan; 132(2):419-26. PubMed ID: 11159690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lovastatin modulation of microglial activation via suppression of functional CD40 expression.
    Townsend KP; Shytle DR; Bai Y; San N; Zeng J; Freeman M; Mori T; Fernandez F; Morgan D; Sanberg P; Tan J
    J Neurosci Res; 2004 Oct; 78(2):167-76. PubMed ID: 15378516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-gamma action.
    Nandan D; Reiner NE
    J Immunol; 1997 Feb; 158(3):1095-101. PubMed ID: 9013947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.